Pellegatti P - Search Results

1

ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment.

Bianchi G, Vuerich M, Pellegatti P, Marimpietri D, Emionite L, Marigo I, Bronte V, Di Virgilio F, Pistoia V, Raffaghello L. Bianchi G, et al. Among authors: pellegatti p. Cell Death Dis. 2014 Mar 20;5(3):e1135. doi: 10.1038/cddis.2014.109. Cell Death Dis. 2014. PMID: 24651438 Free PMC article.

2

A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion.

Pellegatti P, Falzoni S, Pinton P, Rizzuto R, Di Virgilio F. Pellegatti P, et al. Mol Biol Cell. 2005 Aug;16(8):3659-65. doi: 10.1091/mbc.e05-03-0222. Epub 2005 Jun 8. Mol Biol Cell. 2005. PMID: 15944221 Free PMC article.

3

Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase.

Pellegatti P, Raffaghello L, Bianchi G, Piccardi F, Pistoia V, Di Virgilio F. Pellegatti P, et al. PLoS One. 2008 Jul 9;3(7):e2599. doi: 10.1371/journal.pone.0002599. PLoS One. 2008. PMID: 18612415 Free PMC article.

4

Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor.

Adinolfi E, Cirillo M, Woltersdorf R, Falzoni S, Chiozzi P, Pellegatti P, Callegari MG, Sandonà D, Markwardt F, Schmalzing G, Di Virgilio F. Adinolfi E, et al. Among authors: pellegatti p. FASEB J. 2010 Sep;24(9):3393-404. doi: 10.1096/fj.09-153601. Epub 2010 May 7. FASEB J. 2010. PMID: 20453110

5

P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration.

Pellegatti P, Falzoni S, Donvito G, Lemaire I, Di Virgilio F. Pellegatti P, et al. FASEB J. 2011 Apr;25(4):1264-74. doi: 10.1096/fj.10-169854. Epub 2011 Jan 13. FASEB J. 2011. PMID: 21233486

6

A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes.

Cabrini G, Falzoni S, Forchap SL, Pellegatti P, Balboni A, Agostini P, Cuneo A, Castoldi G, Baricordi OR, Di Virgilio F. Cabrini G, et al. Among authors: pellegatti p. J Immunol. 2005 Jul 1;175(1):82-9. doi: 10.4049/jimmunol.175.1.82. J Immunol. 2005. PMID: 15972634

7

The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner.

Tomasinsig L, Pizzirani C, Skerlavaj B, Pellegatti P, Gulinelli S, Tossi A, Di Virgilio F, Zanetti M. Tomasinsig L, et al. Among authors: pellegatti p. J Biol Chem. 2008 Nov 7;283(45):30471-81. doi: 10.1074/jbc.M802185200. Epub 2008 Sep 2. J Biol Chem. 2008. PMID: 18765670 Free PMC article.

8

The P2X7 receptor and Pannexin-1 are both required for the promotion of multinucleated macrophages by the inflammatory cytokine GM-CSF.

Lemaire I, Falzoni S, Zhang B, Pellegatti P, Di Virgilio F. Lemaire I, et al. Among authors: pellegatti p. J Immunol. 2011 Oct 1;187(7):3878-87. doi: 10.4049/jimmunol.1002780. Epub 2011 Aug 24. J Immunol. 2011. PMID: 21865551

9

Involvement of the purinergic P2X7 receptor in the formation of multinucleated giant cells.

Lemaire I, Falzoni S, Leduc N, Zhang B, Pellegatti P, Adinolfi E, Chiozzi P, Di Virgilio F. Lemaire I, et al. Among authors: pellegatti p. J Immunol. 2006 Nov 15;177(10):7257-65. doi: 10.4049/jimmunol.177.10.7257. J Immunol. 2006. PMID: 17082644

10

Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.

Wilhelm K, Ganesan J, Müller T, Dürr C, Grimm M, Beilhack A, Krempl CD, Sorichter S, Gerlach UV, Jüttner E, Zerweck A, Gärtner F, Pellegatti P, Di Virgilio F, Ferrari D, Kambham N, Fisch P, Finke J, Idzko M, Zeiser R. Wilhelm K, et al. Among authors: pellegatti p. Nat Med. 2010 Dec;16(12):1434-8. doi: 10.1038/nm.2242. Epub 2010 Nov 21. Nat Med. 2010. PMID: 21102458

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page